School of Medicine
Showing 1-9 of 9 Results
-
David Scheinker
Clinical Professor, Pediatrics - Endocrinology and Diabetes
BioDavid Scheinker is the Executive Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. He is the Founder and Director of SURF Stanford Medicine, a group that brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals. SURF has implemented and published dozens of projects demonstrating improvements to the quality and efficiency of care. His areas of focus include clinical care delivery, technical improvements to hospital operations, sensor-based and algorithm-enabled telemedicine, and the socioeconomic factors that shape healthcare cost and quality.
Before coming to Stanford, he was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. He received a PhD in theoretical math from The University of California San Diego under Jim Agler. He advises Carta Healthcare, a healthcare analytics company started by former students. -
Sejal Shah
Clinical Assistant Professor, Pediatrics - Endocrinology and Diabetes
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Seth Andrew Sharp
Postdoctoral Scholar, Endocrinology and Metabolism
BioSeth is a Larry L. Hillblom Postdoctoral Fellow in the Translational Genomics of Diabetes laboratory under Dr. Anna Gloyn with co-mentorship in statistical and population genetics from Dr. Manuel Rivas. Seth completed a B.E. in Applied Mathematics before studying a PhD at the University of Exeter with Drs. Richard Oram and Michael Weedon in which he spent significant time at the Pacific Northwest Research Institute developing new statistical models for polygenic risk scores to predict, screen and understand Type 1 diabetes and other autoimmune disorders with screening expert Dr. William Hagopian. Seth was further seconded to the Alan Turing Institute in London where he used deep learning methods to develop neonatal blood spot polygenic risk screening panels. His postdoctoral studies at Stanford now focus on applying "GWAS-in-a-Dish' and "Polygenic Risk Score to Function (PRS2F)' approaches with rich cellular phenotyping from human donor islets to understand the molecular determinants of impaired insulin secretion in diabetes. He is involved in a number of national human islet research networks and gene-perturbation screen efforts aimed at better understanding diabetes, as well as clinical translation studies at Stanford aimed at improving precision medicine approaches to diabetes.
-
Diane Stafford
Clinical Professor, Pediatrics - Endocrinology and Diabetes
BioDr. Stafford specializes in Pediatric Endocrinology with special interest in disorders of puberty and Prader-Willi syndrome (PWS). Her research interests include in medical education curriculum development, faculty development and endocrine dysfunction in PWS.
-
Han Sun
Postdoctoral Scholar, Genetics
Biostatistician 2, Pediatrics - EndocrinologyBioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.
After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes. -
Jacqueline Sunderland
Adm Assoc 4, Pediatrics - Endocrinology
Current Role at StanfordAdministrative Associate, Pediatric Endocrinology & Diabetes
